These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 37251801)

  • 1. Spatial patterns of white matter hyperintensities: a systematic review.
    Botz J; Lohner V; Schirmer MD
    Front Aging Neurosci; 2023; 15():1165324. PubMed ID: 37251801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid-attenuated inversion recovery magnetic resonance imaging textural features as sensitive markers of white matter damage in midlife adults.
    Dounavi ME; Low A; Muniz-Terrera G; Ritchie K; Ritchie CW; Su L; Markus HS; O'Brien JT
    Brain Commun; 2022; 4(3):fcac116. PubMed ID: 35611309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of white matter hyperintensity severity using multimodal magnetic resonance imaging.
    Parent O; Bussy A; Devenyi GA; Dai A; Costantino M; Tullo S; Salaciak A; Bedford S; Farzin S; Béland ML; Valiquette V; Villeneuve S; Poirier J; Tardif CL; Dadar M; ; Chakravarty MM
    Brain Commun; 2023; 5(6):fcad279. PubMed ID: 37953840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular disease promotes tau pathology in Alzheimer's disease.
    Laing KK; Simoes S; Baena-Caldas GP; Lao PJ; Kothiya M; Igwe KC; Chesebro AG; Houck AL; Pedraza L; Hernández AI; Li J; Zimmerman ME; Luchsinger JA; Barone FC; Moreno H; Brickman AM;
    Brain Commun; 2020; 2(2):fcaa132. PubMed ID: 33215083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging.
    Holland CM; Smith EE; Csapo I; Gurol ME; Brylka DA; Killiany RJ; Blacker D; Albert MS; Guttmann CR; Greenberg SM
    Stroke; 2008 Apr; 39(4):1127-33. PubMed ID: 18292383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of White Matter Hyperintensities in Large-Scale MRI-Studies.
    Frey BM; Petersen M; Mayer C; Schulz M; Cheng B; Thomalla G
    Front Neurol; 2019; 10():238. PubMed ID: 30972001
    [No Abstract]   [Full Text] [Related]  

  • 10. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies.
    Ithapu V; Singh V; Lindner C; Austin BP; Hinrichs C; Carlsson CM; Bendlin BB; Johnson SC
    Hum Brain Mapp; 2014 Aug; 35(8):4219-35. PubMed ID: 24510744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies.
    Hu HY; Ou YN; Shen XN; Qu Y; Ma YH; Wang ZT; Dong Q; Tan L; Yu JT
    Neurosci Biobehav Rev; 2021 Jan; 120():16-27. PubMed ID: 33188821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of migraine-related white matter hyperintensities after 3 years: a longitudinal MRI study.
    Erdélyi-Bótor S; Aradi M; Kamson DO; Kovács N; Perlaki G; Orsi G; Nagy SA; Schwarcz A; Dóczi T; Komoly S; Deli G; Trauninger A; Pfund Z
    Headache; 2015 Jan; 55(1):55-70. PubMed ID: 25319529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between amyloid β and white matter hyperintensities: A systematic review.
    Roseborough A; Ramirez J; Black SE; Edwards JD
    Alzheimers Dement; 2017 Oct; 13(10):1154-1167. PubMed ID: 28322203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta-analysis, systematic review, and recommendations for future study harmonization.
    Roseborough AD; Saad L; Goodman M; Cipriano LE; Hachinski VC; Whitehead SN
    Alzheimers Dement; 2023 Jan; 19(1):194-207. PubMed ID: 35319162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
    J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic quantification of white matter hyperintensities on T2-weighted fluid attenuated inversion recovery magnetic resonance imaging.
    Igwe KC; Lao PJ; Vorburger RS; Banerjee A; Rivera A; Chesebro A; Laing K; Manly JJ; Brickman AM
    Magn Reson Imaging; 2022 Jan; 85():71-79. PubMed ID: 34662699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical thickness, white matter hyperintensities, and cognition after stroke.
    Dickie DA; Gardner K; Wagener A; Wyss A; Arba F; Wardlaw JM; Dawson J;
    Int J Stroke; 2020 Jan; 15(1):46-54. PubMed ID: 31088224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.